Atyr Pharma Inc

XNAS:ATYR 4:00:00 PM EDT

0.78

+0.04 (+5.11%)

7:16:40 PM EDT: $0.78 0.00 (-0.40%)

Market Cap (Intraday)	80.65M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.05 Million
Adjusted EPS	-$0.19

See more estimates

10-Day MA	$0.76
50-Day MA	$0.79
200-Day MA	$3.11

See more pivots

Atyr Pharma Inc Stock, XNAS:ATYR

10240 Sorrento Valley Road, Suite 300, San Diego, California 92121

United States of America

Phone: +1.858.731.8389

Number of Employees: 59

http://www.atyrpharma.com

Description

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.